Smart switch: can changing chemo Mid-Treatment improve pancreatic cancer surgery success?
NCT ID NCT04539808
Summary
This study is testing a flexible treatment plan for people with pancreatic cancer that might be removable by surgery. Doctors will give one chemotherapy combination first, then switch to a different one if the cancer isn't responding well or if side effects are too severe. The goal is to shrink the tumor as much as possible before surgery to improve the chance of removing all the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.